Michael Kaseta - 30 Jan 2026 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
Director
Signature
/s/Kathryn Lester Attorney-in-fact for Michael Kaseta
Issuer symbol
HRTX
Transactions as of
30 Jan 2026
Net transactions value
$0
Form type
4
Filing time
03 Feb 2026, 10:00:11 UTC
Previous filing
21 Jan 2026
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kaseta Michael Director 100 REGENCY FOREST DRIVE, SUITE 300, CARY /s/Kathryn Lester Attorney-in-fact for Michael Kaseta 03 Feb 2026 0001724346

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRTX Common Stock Award $0 +53,960 $0.000000 53,960 30 Jan 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were granted as restricted stock units which vest in full on January 30, 2027. Each restricted stock unit represents a contigent right to receive one share of common stock.